Current Opinion in Virology

Papers
(The TQCC of Current Opinion in Virology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial Board59
Colonization of peripheral ganglia by herpes simplex virus type 1 and 255
The enigmatic roles of Anelloviridae and Redondoviridae in humans43
Transmission patterns of hepatitis E virus40
A novel antiviral strategy by disrupting the equilibrium of virus-host calcium homeostasis39
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-1935
Inhaled aerosol viral-vectored vaccines against tuberculosis34
Hepatitis-B virus: replication cycle, targets, and antiviral approaches32
Editorial Board29
Editorial overview: Viral pathogenesis27
Intercellular highways of viral spread: tunneling nanotubes and extracellular vesicles at the maternal–fetal interface24
Human placental models for studying viral infections24
Editorial Board24
Viral–host interactions during splicing and nuclear export of influenza virus mRNAs24
The two faces of oligoadenylate synthetase-like: effective antiviral protein and negative regulator of innate immunity23
Paramyxoviruses from bats: changes in receptor specificity and their role in host adaptation23
Editorial Board22
A review of broadly protective monoclonal antibodies to treat Ebola virus disease22
A complex immune communication between eicosanoids and pulmonary macrophages22
Hemagglutinin stability as a key determinant of influenza A virus transmission via air21
Role of mucosal-associated invariant T cells in coronavirus disease 2019 vaccine immunogenicity21
Retasking of canonical antiviral factors into proviral effectors21
Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities21
Human organoid models to study coronavirus infections of the respiratory tract20
Tissue-resident memory T cells in protective immunity to influenza virus19
Does arbovirus emergence in humans require adaptation to domestic mosquitoes?19
Modeling zoonotic and vector-borne viruses18
Oncogenic Animal Herpesviruses18
MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases17
State-of-the-art in oncolytic virotherapy using adenoviruses other than the commonly applied adenovirus type 517
Role of the viral polymerase during adaptation of influenza A viruses to new hosts17
Diagnosis and monitoring of virus-associated cancer using cell-free DNA17
Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy16
Nexus of virus and brain: recent advances in flavivirus and enterovirus neuro-infection16
MicroRNA-mediated control of Epstein–Barr virus infection and potential diagnostic and therapeutic implications16
Deimmunization of flagellin adjuvant for clinical application16
Severe fever with thrombocytopenia syndrome virus NSs: a multifaceted viral protein in host–virus interactions15
Sequence variability of the K1 gene in Kaposi’s sarcoma-associated herpesvirus and its role in pathogenesis15
0.97583794593811